Search for: "In Re Medical Review Panel" Results 61 - 80 of 888
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jun 2009, 3:27 am
(In re Reglan/Metoclopramide Products Liability Litigation, MDL No. 2049, 6/3/09). [read post]
14 Jan 2021, 9:05 pm by Lynn McDonough
The post Week in Review first appeared on The Regulatory Review. [read post]
28 May 2023, 4:37 am by Robert George
" Our panelists were Kristen Collier of the University of Michigan Medical School; J. [read post]
9 Sep 2011, 7:07 am by Ed Wallis
The review of the mesh is also said to be connected to criticism of the FDA’s 510(k) process, which critics say allows for use of medical devices without sufficient testing. [read post]
13 Jan 2010, 12:55 am by Dr. Shezad Malik
Since 2007, the F.D.A. has held three advisory panel meetings on these drugs and has changed the labels of the drugs to warn of risks and lower the doses used. [read post]
17 Jul 2012, 5:00 pm
In the review process, cancer survivors - known as "consumer members" - are encouraged to participate and help other members of the review panel award approximately $15 million to programs available for grant funding. [read post]
17 Jul 2012, 5:00 pm
In the review process, cancer survivors - known as "consumer members" - are encouraged to participate and help other members of the review panel award approximately $15 million to programs available for grant funding. [read post]
25 Aug 2011, 4:57 am by Timothy P. Flynn
Some "On-the-Take" physicians conduct cursory reviews of an applicants' medical records in their assessment of a claimed chronic or debilitating medical condition, as required under the Act. [read post]
5 Feb 2018, 12:56 pm by Michael B. Stack
What we know is that medical management, medical costs, medical complexity only continue to increase. [read post]
5 May 2013, 7:25 pm by David Jensen
Finally, the standard deviation on the 2012 peer review was extremely high and the re-review by the three member committee resulted in a split decision. [read post]
8 May 2012, 8:43 am by Rebecca Tushnet
  Written from consumer protection perspective to avoid medication errors. [read post]
23 Apr 2012, 12:02 pm by Jeffrey J. Randa
In particular, we'll review the urine test that is a required part of any Michigan Driver's License Appeal. [read post]
4 Mar 2012, 12:47 pm by Rick
For two reasons, actually, I expect the California Supreme Court to take it up for review. [read post]
19 Feb 2013, 6:45 am by Ed Silverman
It will also increase FDA’s access to external expertise to improve the drug review process. [read post]
31 Jul 2012, 10:07 am by Jerri Lynn Ward, J.D.
Review of Agency Rules The Texas Medical Board proposed to review Chapter 189, Compliance Program, §§189.1 – 189.14, pursuant to the Texas Government Code, §2001.039. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and… [read post]
26 Nov 2012, 6:49 am
" These include new rate review rules (say that 3 times fast!) [read post]
11 Oct 2016, 10:35 am by Thaddeus Mason Pope, JD, PhD
The symposium features four panels and a keynote speaker during lunch. [read post]